New Penn-Designed Gel Allows for Targeted Therapy After Heart Attack

Combatting the tissue degrading enzymes that cause lasting damage following a heart attack is tricky. Each patient responds to a heart attack differently and damage can vary from one part of the heart muscle to another, but existing treatments can’t be fine-tuned to deal with this variation.

Targeting miR-30d reverses pathological cardiac hypertrophy - eBioMedicine

Therapies to prevent post-infarction remodelling: From repair to regeneration - ScienceDirect

Archived News, Penn Institute for Immunology

Cells, Free Full-Text

Novel Dual CAR T Cell Immunotherapy Holds Promise for Targeting the HIV Reservoir

Intravitreal hydrogels for sustained release of therapeutic proteins - ScienceDirect

FDA Approves “Glowing Tumor” Imaging Drug for Lung Cancer Surgery

Stem cell therapy for heart failure: Medical breakthrough, or dead end?

Hyaluronan and elastin-like protein (HELP) gels significantly improve microsphere retention in the myocardium - Biomaterials Science (RSC Publishing) DOI:10.1039/D1BM01890F

Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins

Drug and cell delivery for cardiac regeneration - ScienceDirect

Transcriptomic Analysis Identifies the Effect of Beta-Blocking Agents on a Molecular Pathway of Contraction in the Heart and Predicts Response to Therapy